AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Perspective Therapeutics, Inc. Director's Dealing 2010

Jul 2, 2010

33510_dirs_2010-07-02_6860b5b8-e9f3-4926-b3c5-a7399bcad7ea.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2010-06-30

Reporting Person: Ragle Brien (Controller)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-06-30	Stock option (right to buy)	$1.43	A	20000	Acquired	2020-06-30	common stock (20000)	Direct

Footnotes

F1: 6,666 will become exercisable on June 30, 2011, 6,666 will become exercisable on June 30, 2012, and 6,667 will become exercisable on June 30, 2013.